# Taizo A. Nakano, M.D. – FDA Inspection, Feb 28, 2025

Source: https://www.keypedia.com/records/fda_inspections/taizo-a-nakano-md/b2268ec6-6e12-447a-b970-9fbac4b76843
Source feed: FDA_Inspections

> FDA inspection 1262737 of Taizo A. Nakano, M.D., February 28, 2025. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 312. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1262737
- Company Name: Taizo A. Nakano, M.D.
- Inspection Date: 2025-02-28
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring: Human Drugs
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Denver District Office
- Citation Count: 2

## Related Officers

- [Company Rep](https://www.keypedia.com/people/farwa-z-razvi/4ac4d0de-addf-4657-8756-0676015cea8a)

Company: https://www.keypedia.com/companies/taizo-a-nakano-md/accd92a6-b042-4b0b-a128-18e12b9a7848

Office: https://www.keypedia.com/offices/denver-district-office/93b79063-390c-4759-af6c-5da7e388face
